ICU Medical Inc(ICUI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | 132.18 | EPS (ttm) | 1.18 | Insider Own | 1.77% | Shs Outstand | 25.0M | Perf Week | -5.9% |
| Market Cap | 3.91B | Forward P/E | 16.19 | EPS next Y | 10.61% | Insider Trans | -9.14% | Shs Float | 24.6M | Perf Month | -12.75% |
| Enterprise Value | 4.90B | PEG | 1.58 | EPS next Q | 2.14 | Inst Own | 104.54% | Short Float | 5.84% | Perf Quarter | 9.53% |
| Income | 0.03B | P/S | 1.81 | EPS this Y | 12.63% | Inst Trans | 2.67% | Short Ratio | 4.8 | Perf Half Y | 21.51% |
| Sales | 2.16B | P/B | 1.82 | EPS next 5Y | 10.24% | ROA | 0.74% | Short Interest | 1.43M | Perf YTD | 9.68% |
| Book/sh | 86.05 | P/C | 13.12 | EPS past 3/5Y | - -62.61% | ROE | 1.41% | 52W High | -18.86% ($192.85) | Perf Year | 15.89% |
| Cash/sh | 11.93 | P/FCF | 25.6 | Sales past 3/5Y | -0.68% 11.9% | ROIC | 0.88% | 52W Low | 39.09% ($112.50) | Perf 3Y | 21.65% |
| Dividend Est. | - | EV/EBITDA | 14.05 | EPS Y/Y TTM | 179.33% | Gross Margin | 34.5% | Volatility(W/M) | 3.41% 2.56% | Perf 5Y | -35.88% |
| Dividend TTM | - | EV/Sales | 2.27 | Sales Y/Y TTM | -8.84% | Oper. Margin | 6.68% | ATR (14) | 5.35 | Perf 10Y | 28.23% |
| Dividend Ex-Date | - | Quick Ratio | 1.17 | EPS Q/Q | -46.71% | Profit Margin | 1.39% | RSI (14) | 29.73 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.39 | Sales Q/Q | 0.64% | SMA20 | -10.06% ($173.98) | Beta | 0.87 | Target Price | $195.57 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 2026/8/6 | SMA50 | -6.91% ($168.1) | Rel Volume | 0.62 | Prev Close | $157.26 |
| Employees | 13000 | LT Debt/Eq | 0.58 | EPS/Sales Surpr. | 23.85% 2.71% | SMA200 | 7.13% ($146.07) | Avg Volume(3M) | 0.30M | Price | $156.48 |
| IPO | 1992/3/31 | Option/Short | Yes/Yes | Trades | 5124 | Volume | 184,470 | Change | -0.5% |
Company
ICUI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. medical device company that supplies IV infusion systems and medical consumables. It provides hospitals with medical devices and consumables, including infusion pumps, IV administration sets, and critical care monitoring products, and is characterized by recurring consumables revenue. The company operates in the IV infusion and medical consumables sector.
Over the past 1 year, roughly in the middle
19% below its 1-year high.
ICUI makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.6% this year.
Tap to view numbers
The stock looks undervalued
Trading at 132.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +21.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 104.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
LFSC 0.02%
PSCH 0.02%
XHE 0.02%
APPC 0.01%
JPSV 0.01%It ranks #4 in the industry
Based on market cap of $4B.
ICUI $4B PER 132.2
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is ICUI?
ICUI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ICUI?
The market cap of ICUI is approximately $3.9B, ranking 1,581 within its sector.
What is the P/E ratio of ICUI?
ICUI has a P/E ratio of approximately 132.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ICUI?
ICUI has recorded a 52-week high of $192.85 and a low of $112.50.
